Recent Updates
Recently added Catalysts
MDXG Positive Sentiment

MIMEDX to Host Fourth Quarter and Full Year 2025 Operating and Financial Results Conference Call on February 25

Key Takeaway: MiMedx Group, Inc. will announce its operating and financial results for Q4 and the full year 2025 on February 25, 2026. The results will be shared during a conference call hosted by the senior management team at 4:30 p.m. ET. Investors can access the call via a dedicated phone line or webcast.
Price reaction · baseline $5.12 (2026-02-13 close) · hit pre-market · clean, no other MDXG news in the window
day 0 close · peak
+0.8%

Market Sentiment Analysis

POSITIVE FACTORS

  • MIMEDX is reporting strong operating and financial results.
  • The company continues to innovate in wound care solutions.
  • The upcoming conference call provides transparency for investors.

BiopharmaWatch Analysis

From our catalyst data and publicly available data · not financial advice
Cash runway
~40 mo
Low dilution risk
Lead asset
Micronized DHACM
Phase 3 · Tendonitis;Achilles

Full Press Release Details

MARIETTA, Ga., Feb. 17, 2026 (GLOBE NEWSWIRE) -- MiMedx Group, Inc. (Nasdaq: MDXG) (“MIMEDX” or the “Company”) today announced that it will report its operating and financial results for the fourth quarter and full year ended December 31, 2025 after the market close on Wednesday, February 25, 2026. The MIMEDX senior management team will host a webcast and conference call to review its results beginning at 4:30 p.m. Eastern Time on the same day.
The conference call can be accessed using the following information:
Webcast:Click hereU.S. Investors: 877-407-6184International Investors: 201-389-0877Conference ID: 13758446
A replay of the webcast will be available for approximately 30 days on the Company’s website atwww.mimedx.comfollowing the conclusion of the event.
About MIMEDXMIMEDX is a pioneer and leader focused on helping humans heal. With more than a decade and a half of helping clinicians manage chronic and other hard-to-heal wounds, MIMEDX provides a leading portfolio of products for applications in the wound care, burn, and surgical sectors of healthcare. The Company’s vision is to be the leading global provider of healing solutions through relentless innovation to restore quality of life. For additional information, please visitwww.mimedx.com.

Contact:Matt NotarianniInvestor Relations470-304-7291mnotarianni@mimedx.com

Frequently Asked Questions

When will MIMEDX report its Q4 2025 results?

MIMEDX will report its Q4 2025 results on February 25, 2026.

What time is the MIMEDX conference call?

The conference call will begin at 4:30 p.m. Eastern Time.

How can I access the MIMEDX conference call?

Access the call via U.S. Investors at 877-407-6184 or International Investors at 201-389-0877.

Is there a replay available for the conference call?

Yes, a replay will be available for approximately 30 days on the MIMEDX website.

Last updated: Feb 17, 2026